Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults With CD20+ Mature B-Cell Lymphoma

NCT01859819 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

NCT NCT01859819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01859819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults With CD20+ Mature B-Cell Lymphoma
Lead sponsor
New York Medical College
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
June 30, 2021
Enrollment
45 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

burkitt's lymphoma, diffuse large cell lymphoma, high grade b-cell lymphoma